ZANETTI, MICHELA
 Distribuzione geografica
Continente #
NA - Nord America 15.304
EU - Europa 7.514
AS - Asia 3.660
SA - Sud America 441
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 19
Totale 27.047
Nazione #
US - Stati Uniti d'America 15.220
PL - Polonia 1.679
IT - Italia 1.541
SG - Singapore 1.158
CN - Cina 1.128
SE - Svezia 1.022
UA - Ucraina 826
HK - Hong Kong 738
DE - Germania 520
BR - Brasile 348
FI - Finlandia 342
RU - Federazione Russa 321
TR - Turchia 279
FR - Francia 263
GB - Regno Unito 191
IE - Irlanda 183
BG - Bulgaria 182
NL - Olanda 175
BE - Belgio 61
IN - India 58
JP - Giappone 58
CH - Svizzera 46
ES - Italia 45
CA - Canada 38
SN - Senegal 34
VN - Vietnam 34
MX - Messico 29
ID - Indonesia 28
PE - Perù 27
KR - Corea 26
AT - Austria 24
PH - Filippine 20
AR - Argentina 18
EC - Ecuador 16
EU - Europa 16
TW - Taiwan 16
RO - Romania 15
AU - Australia 14
BD - Bangladesh 14
CZ - Repubblica Ceca 14
EG - Egitto 14
PT - Portogallo 13
IR - Iran 12
CO - Colombia 11
IL - Israele 11
ZA - Sudafrica 11
AE - Emirati Arabi Uniti 9
CL - Cile 9
MY - Malesia 9
PK - Pakistan 9
A2 - ???statistics.table.value.countryCode.A2??? 8
MA - Marocco 8
DK - Danimarca 7
IQ - Iraq 7
SA - Arabia Saudita 7
TH - Thailandia 7
LT - Lituania 6
RS - Serbia 6
KE - Kenya 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
VE - Venezuela 5
AZ - Azerbaigian 4
CR - Costa Rica 4
HR - Croazia 4
KG - Kirghizistan 4
LA - Repubblica Popolare Democratica del Laos 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
BN - Brunei Darussalam 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
GR - Grecia 3
JM - Giamaica 3
MD - Moldavia 3
PY - Paraguay 3
AM - Armenia 2
CU - Cuba 2
DZ - Algeria 2
EE - Estonia 2
GT - Guatemala 2
HU - Ungheria 2
KW - Kuwait 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
BF - Burkina Faso 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CY - Cipro 1
GH - Ghana 1
HN - Honduras 1
IS - Islanda 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 27.037
Città #
Woodbridge 2.043
Fairfield 1.816
Warsaw 1.643
Houston 1.546
Ann Arbor 1.398
Chandler 1.079
Ashburn 1.058
Wilmington 852
Seattle 804
Jacksonville 773
Hong Kong 728
Singapore 665
Cambridge 602
Trieste 466
Boardman 365
Princeton 317
Beijing 251
Izmir 216
Columbus 194
Dublin 182
Sofia 182
Moscow 141
Hefei 126
Dearborn 103
Milan 101
San Diego 100
Frankfurt am Main 92
Santa Clara 91
Düsseldorf 75
Grafing 64
Helsinki 56
Brussels 52
Munich 52
Los Angeles 51
Rome 50
Redmond 49
Falls Church 47
Des Moines 41
Shanghai 39
Chicago 37
Norwalk 36
Dakar 34
Jinan 34
Bremen 33
Nuremberg 30
São Paulo 30
Verona 29
Washington 29
Nanjing 28
Bern 27
Dallas 27
Lima 26
Buffalo 25
Kocaeli 25
Phoenix 25
Dong Ket 24
London 24
Shenyang 24
Guangzhou 22
Turku 22
Seoul 21
Venice 21
Lauterbourg 20
Pune 19
Redwood City 19
San Francisco 19
Toronto 19
Genoa 18
The Dalles 18
Tokyo 18
Belo Horizonte 17
Brooklyn 17
New York 16
Udine 16
Fremont 15
Hangzhou 15
Kunming 15
Paris 15
Venezia 15
Zhengzhou 15
Ancona 14
Rio de Janeiro 14
Roubaix 14
Wroclaw 14
Bologna 13
Chengdu 13
Florence 13
Hebei 13
Mestre 13
Taipei 13
Wuhan 13
Zurich 13
Ankara 12
Lappeenranta 12
Turin 12
Brno 11
Chongqing 11
Madrid 11
Naples 11
Portsmouth 11
Totale 19.700
Nome #
Unacylated ghrelin reduces skeletal muscle reactive oxygen species generation and inflammation and prevents high-fat diet-induced hyperglycemia and whole-body insulin resistance in rodents 406
Omega-3 Polyunsaturated Fatty Acids: Structural and Functional Effects on the Vascular Wall 347
Unacylated ghrelin does not alter mitochondrial function, redox state and triglyceride content in rat liver in vivo 338
Update on the impact of omega 3 fatty acids on inflammation, insulin resistance and sarcopenia: A review 332
Lack of Fibronectin Extra Domain A Alternative Splicing Exacerbates Endothelial Dysfunction in Diabetes 315
Omega 3 Polyunsaturated Fatty Acids Improve Endothelial Dysfunction in Chronic Renal Failure: Role of eNOS Activation and of Oxidative Stress 305
Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure 293
Black esophagus 293
Poor nutritional status but not cognitive or functional impairment per se independently predict 1 year mortality in elderly patients with hip-fracture 268
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 255
Central adiposity markers, plasma lipid profile and cardiometabolic risk prediction in overweight-obese individuals 252
Adipokines, Ghrelin and Obesity-Associated Insulin Resistance in Nondiabetic Patients with Acute Coronary Syndrome. 229
Unacylated ghrelin improves vascular dysfunction and attenuates atherosclerosis during high-fat diet consumption in rodents 226
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 225
Acylated Ghrelin Limits Fat Accumulation and Improves Redox State and Inflammation Markers in the Liver of High-Fat-Fed Rats. 219
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 214
Decreased VLDL-Apo B 100 fractional synthesis rate despite hypertriglyceridemia in subjects with type 2 diabetes and nephropathy 213
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 213
High-fat diet with acyl-ghrelin treatment leads to weight gain with low inflammation, high oxidative capacity and normal triglycerides in rat muscle. 210
Identifying reliable predictors of protein-energy malnutrition in hospitalized frail older adults. A prospective longitudinal study 210
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome 206
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 206
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 203
Sepsis outside intensive care unit: the other side of the coin 202
Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease 196
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 195
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 193
Treatment with n-3 Polyunsaturated Fatty Acids Reverses Endothelial Dysfunction and Oxidative Stress in Experimental Menopause 193
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 189
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 184
Prediction of early- and long-term mortality in adult patients acutely admitted to internal medicine: NRS-2002 and beyond 183
Analysis of superoxide anion production in tissue. 180
Baroreflex sensitivity and central hemodynamics after omega-3 polyunsaturated fatty acids supplementation in an animal model of menopause 175
Relation between the plasma levels of LDL-cholesterol and the expression of the early marker of inflammation long pentraxin PTX3 and the stress response gene p66ShcA in pacemaker-implanted patients. 173
Nutrizione artificiale nell’anziano critico: può prevenire e trattare la sarcopenia. 173
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 173
Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers 171
Adenoviral-mediated overexpression of catalase inhibits endothelial cell proliferation 170
Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)-nuclear factor-κB (NFκB) activation in rat muscle, in the absence of mitochondrial dysfunction. 169
Supplementation of Omega-3 Polyunsaturated Fatty Acids Prevents Increase in Arterial Stiffness After Experimental Menopause 169
Calorie restriction modulates inactivity-induced changes in the inflammatory markers C-reactive protein and pentraxin-3 163
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards 161
Insulin infusion normalizes fasting and post-prandial albumin and fibrinogen synthesis in type 1 diabetes mellitus 160
Disseminated tuberculosis in an immunocompetent patient 157
Plasma total and unacylated ghrelin predict 5-year changes in insulin resistance 157
null 155
Acute Infusion of N-3 Polyunsaturated (N-3 PUFA) Fatty Acids is not Associated with Enhanced Reactive Oxygen Species Generation and Lowers Mitochondrial ATP Production in Rat Liver 153
null 152
Kidney, splanchnic and leg protein turnover in humans. Insight from leucine and phenylalanine kinetics 149
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 149
Effects of wine intake on postprandial plasma amino acid and protein kinetics in type 1 diabetes 148
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 147
null 146
Leucine metabolism and protein dynamics in the human kidney 145
Superoxide anions and endothelial cell proliferation in normoglycemia and hyperglycemia 145
A model of skeletal muscle leucine kinetics measured across the human forearm. 145
Time-dependent changes in plasma total, acylated and desacylated ghrelin after gastric by-pass 143
The role of substrates in the regulation of protein metabolism. 143
Hyperglucagonemia stimulates phenylalanine oxidation in humans. 143
Protein degradation and synthesis measured with multiple amino acid tracers in vivo. 140
n-3-Pufa Dietary Enrichment Improves Whole-Body Insulin Action and Normalizes Muscle Mass, Mitochondrial Function, Oxidative Stress, and Insulin Signalling in Experimental Uremia 140
Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations. 139
Impact of a natural versus commercial enteral-feeding on the occurrence of diarrhea in critically ill cardiac surgery patients. A retrospective cohort study 139
n-3 PUFA dietary lipid replacement normalizes muscle mitochondrial function and oxidative stress through enhanced tissue mitophagy and protects from muscle wasting in experimental kidney disease 138
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 138
Comparison of Disease Clusters in Two Elderly Populations Hospitalized in 2008 and 2010 138
null 138
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 138
Evidence for acute stimulation of fibrinogen production by glucagon in humans 137
Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study. 137
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 135
null 134
Protein metabolism in glucagonoma. 134
Effects of branched-chain-enriched amino acids and insulin on forearm leucine kinetics. 134
Gene transfer of manganese superoxide dismutase reverses vascular dysfunction in the absence but not in the presence of atherosclerotic plaque. 133
Gene transfer of superoxide dismutase isoforms reverses endothelial dysfunction in diabetic rabbit aorta. 133
Differential Cross-Sectional and Prospective Predictive Value for Insulin Resistance of Different Anthropometric Indexes and Parameters in A North-East Italy Community-Based Population Cohort 133
Prognostic factors of poor hospital outcome: A joined role for nutritional, co-morbidity and nursing screening tests 133
null 132
Perioperative nutritional support. 132
Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: Validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile 131
Role of blood cells in leucine kinetics across the human kidney 128
null 128
Response of phenylalanine and leucine kinetics to branched chain-enriched amino acids and insulin in patients with cirrhosis. 127
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 127
Intravenous lipid infusion and total plasma fatty acids positively modulate plasma acylated ghrelin in vivo 126
null 125
Differences in estimates of forearm protein synthesis between leucine and phenylalanine tracers following unbalanced amino acid infusion. 124
Defining and diagnosing sarcopenia: Is the glass now half full? 123
null 123
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People 122
Gene transfer of endothelial nitric oxide synthase alters endothelium-dependent relaxations in aortas from diabetic rabbits 121
null 121
null 121
null 121
Negative association between plasma desacylated Ghrelin and carotid artery intima-media thickness in females with the Metabolic Syndrome 120
Fasting and postprandial phenylalanine and leucine kinetics in liver cirrhosis 120
null 119
Unacylated Ghrelin Normalizes Oxidative Stress and Insulin Action in Rat Muscle and Prevents Muscle Loss in Experimental Uremia 119
null 118
Totale 17.246
Categoria #
all - tutte 83.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.844


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020254 0 0 0 0 0 0 0 0 0 0 0 254
2020/20213.302 276 196 308 371 280 308 268 279 175 402 149 290
2021/20222.142 96 141 61 172 68 226 101 89 238 220 220 510
2022/20233.129 283 414 233 470 323 519 42 235 364 38 149 59
2023/20242.141 174 211 116 119 177 186 314 372 28 74 193 177
2024/20255.004 120 235 326 474 528 531 442 322 626 576 395 429
Totale 27.927